Highly Sensitive Detection of Complicated Mutations of Drug Resistance in Mycobacterium tuberculosis Using a Simple, Accurate, Rapid, and Low‐Cost Tailored‐Design Competitive Wild‐Type Blocking Assay
Small Methods · 2023
DOI: 10.1002/smtd.202201322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2023. Verfasst von Mengqiu Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering/Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Establishing simple, rapid, and highly sensitive molecular assays is crucial for timely diagnosis and effective treatment of drug‐resistant tuberculosis. However, current genotypic drug susceptibility testing (DST) still encounters enormous challenges including lower sensitivity than phenotypic DST and insufficient accuracy. Herein, a simple, low‐cost, multiplex real‐time polymerase chain reaction‐based assay is established to achieve highly sensitive detection of low‐abundant mutants through competitive wild‐type blocking (COWTB). Analytical performance of the COWTB assay can achieve 1% or even 0.1% mutants under background of 10 000 wild‐type genomes/test. Furthermore, clinical practice feasibility is evaluated to identify resistance to rifampicin (RIF), isoniazid (INH), and streptomycin (SM) on 92 actual clinical samples, its sensitivity is 93.8% for RIF and 100% for INH and SM, and specificity is 100% each for RIF, INH, and SM when using DNA sequencing as the reference standard. In comparison, the sensitivity of reverse dot blotting assay commonly used in clinics is 93.8%, 90.0%, and 84.6%, and the specificity is 96.1%, 98.6%, and 100% for RIF, INH, and SM, respectively. Importantly, the COWTB assay can also be applicable for other drug‐resistant mutations and pave a promising detection strategy to fill the gap between phenotypic and genotypic DST for detecting low‐abundant drug‐resistant M. tuberculosis .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering/Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
- Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.
- Department of Clinical Laboratory Medicine, People's Hospital of Ningxia Hui Autonomous Region (First Affiliated Hospital of Northwest Minzu University), Yinchuan, 750002, P. R. China.
ORCID-Profile: Hong Xu, Binwu Ying
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, M., Zhao, Z., Wu, T., Liu, T., Xu, G., Xu, H., & Ying, B. (2023). Highly Sensitive Detection of Complicated Mutations of Drug Resistance in Mycobacterium tuberculosis Using a Simple, Accurate, Rapid, and Low‐Cost Tailored‐Design Competitive Wild‐Type Blocking Assay. Small Methods. https://doi.org/10.1002/smtd.202201322
Vancouver
Yan M, Zhao Z, Wu T, Liu T, Xu G, Xu H, et al. Highly Sensitive Detection of Complicated Mutations of Drug Resistance in Mycobacterium tuberculosis Using a Simple, Accurate, Rapid, and Low‐Cost Tailored‐Design Competitive Wild‐Type Blocking Assay. Small Methods. 2023. doi:10.1002/smtd.202201322
BibTeX
@article{Yan2023,
author = {Yan, Mengqiu and Zhao, Zhenzhen and Wu, Tao and Liu, Tangyuheng and Xu, Gaolian and Xu, Hong and Ying, Binwu},
title = {Highly Sensitive Detection of Complicated Mutations of Drug Resistance in Mycobacterium tuberculosis Using a Simple, Accurate, Rapid, and Low‐Cost Tailored‐Design Competitive Wild‐Type Blocking Assay},
journal = {Small Methods},
year = {2023},
doi = {10.1002/smtd.202201322}
}
EUVIMED